CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 494606-494854 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"This was correlated with the observation that Bortezomib efficiently reduced production of anti AChR antibody titers (by 67% in the Prevention group and by 65% in the Treatment group) and improved neuromuscular transmission in the prevention group.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T85491","span":{"begin":0,"end":248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T85491","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1096","span":{"begin":0,"end":248},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1096","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T309","span":{"begin":0,"end":248},"obj":"Sentence"}],"attributes":[{"subj":"T309","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#e193ec","default":true},{"id":"Epistemic_Statements","color":"#93ecc7"},{"id":"CORD-19_Custom_license_subset","color":"#ecad93"}]}]}}